...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: What's the deal with Zenith?

Who would actually be interested in purchasing a portion of Zenith owned RVX royalties/shares?

I would think it would almost have to be one of the Zenith BP partners or investors. Great way to pull them in deeper, and visualize (and maybe own) both companies someday?

This smells like an orchestration of a future BP roll up to me, in theory. And creatively using non-equity instruments for RVX financing, for keeping both entities healthy and progressing. 

Pretty clever, love it ... if it is anything close to what I am smelling.

Share
New Message
Please login to post a reply